The Role of Fecal Fusobacterium nucleatum and pks+ Escherichia coli as Early Diagnostic Markers of Colorectal Cancer. (22nd November 2021)
- Record Type:
- Journal Article
- Title:
- The Role of Fecal Fusobacterium nucleatum and pks+ Escherichia coli as Early Diagnostic Markers of Colorectal Cancer. (22nd November 2021)
- Main Title:
- The Role of Fecal Fusobacterium nucleatum and pks+ Escherichia coli as Early Diagnostic Markers of Colorectal Cancer
- Authors:
- Liu, Kaixi
Yang, Xinran
Zeng, Mi
Yuan, Yumeng
Sun, Jianhong
He, Ping
Sun, Jiayu
Xie, Qingdong
Chang, Xiaolan
Zhang, Suwei
Chen, Xiang
Cai, Leshan
Xie, Yanxuan
Jiao, Xiaoyang - Other Names:
- Malaguarnera Michele Academic Editor.
- Abstract:
- Abstract : Background . Accurate analysis of intestinal microbiota will facilitate establishment of an evaluating system for assessing colorectal cancer (CRC) risk and prognosis. This study evaluates the potential role of Fusobacterium nucleatum ( F. nucleatum ) and Escherichia coli with a pks gene ( pks + E. coli ) in early CRC diagnosis. Methods . We recruited 139 patients, including CRC (n = 60 ), colorectal adenomatous polyposis (CAP) (n = 37 ), and healthy individuals (n = 42 ) based on their colonoscopy examinations. We collected stool and serum samples from the participants and measured the relative abundance of F. nucleatum and pks + E. coli in fecal samples by quantitative PCR. Receiver operating characteristic curve (ROC) analyses were used to analyze the diagnostic value of single or combined biomarkers. Results . Fecal F. nucleatum and pks + E. coli levels were higher in the CRC group in either the CAP group or healthy controls (P = 0.02 ; 0.01). There was no statistical difference in the distribution of F. nucleatum and pks + E. coli in patients with different tumor sites (P > 0.05 ). The combination of F. nucleatum + pks + E. coli +CEA+CA19-9+FOBT was chosen as the optimal panel in differentiating both CRC and CAP from the controls. The combination of F. nucleatum, pks + E. coli, and FOBT improved diagnostic efficiency. However, there was difficulty in differentiating CRC from CAP. Conclusion . Our results suggested that combining bacterial markers withAbstract : Background . Accurate analysis of intestinal microbiota will facilitate establishment of an evaluating system for assessing colorectal cancer (CRC) risk and prognosis. This study evaluates the potential role of Fusobacterium nucleatum ( F. nucleatum ) and Escherichia coli with a pks gene ( pks + E. coli ) in early CRC diagnosis. Methods . We recruited 139 patients, including CRC (n = 60 ), colorectal adenomatous polyposis (CAP) (n = 37 ), and healthy individuals (n = 42 ) based on their colonoscopy examinations. We collected stool and serum samples from the participants and measured the relative abundance of F. nucleatum and pks + E. coli in fecal samples by quantitative PCR. Receiver operating characteristic curve (ROC) analyses were used to analyze the diagnostic value of single or combined biomarkers. Results . Fecal F. nucleatum and pks + E. coli levels were higher in the CRC group in either the CAP group or healthy controls (P = 0.02 ; 0.01). There was no statistical difference in the distribution of F. nucleatum and pks + E. coli in patients with different tumor sites (P > 0.05 ). The combination of F. nucleatum + pks + E. coli +CEA+CA19-9+FOBT was chosen as the optimal panel in differentiating both CRC and CAP from the controls. The combination of F. nucleatum, pks + E. coli, and FOBT improved diagnostic efficiency. However, there was difficulty in differentiating CRC from CAP. Conclusion . Our results suggested that combining bacterial markers with conventional tumor markers improves the diagnostic efficiency for noninvasive diagnosis of CRC. … (more)
- Is Part Of:
- Disease markers. Volume 2021(2021)
- Journal:
- Disease markers
- Issue:
- Volume 2021(2021)
- Issue Display:
- Volume 2021, Issue 2021 (2021)
- Year:
- 2021
- Volume:
- 2021
- Issue:
- 2021
- Issue Sort Value:
- 2021-2021-2021-0000
- Page Start:
- Page End:
- Publication Date:
- 2021-11-22
- Subjects:
- Diagnosis -- Periodicals
Biochemical markers -- Periodicals
Pathology -- Periodicals
616 - Journal URLs:
- https://www.hindawi.com/journals/dm/ ↗
- DOI:
- 10.1155/2021/1171239 ↗
- Languages:
- English
- ISSNs:
- 0278-0240
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library HMNTS - ELD Digital store
- Ingest File:
- 20158.xml